IPAD-DB ID | C00834 |
Name | Resveratrol diglucoside |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | - |
Molecular Weight | - |
IUPAC Name | (E)-4-(3-hydroxy-5-(2-hydroxyacetoxy)styryl)phenyl 2-hydroxyacetate |
InChI | InChI=1S/C18H16O7/c19-10-17(22)24-15-5-3-12(4-6-15)1-2-13-7-14(21)9-16(8-13)25-18(23)11-20/h1-9, 19-21H, 10-11H2/b2-1+ |
InChIKey | IUFDIOUYEPNXOG-OWOJBTEDSA-N |
Canonical SMILES | OC1=CC(OC(CO)=O)=CC(/C=C/C2=CC=C(C([H])=C2)OC(CO)=O)=C1 |
PubChem CID | - |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 344.32 |
Hac(Computed by SwissADME) | 25 |
Volume(Computed by ADMETlab 2.0) | 340.575 |
Density(Computed by ADMETlab 2.0) | 1.01 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 7 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 15 |
Flexibility(Computed by ADMETlab 2.0) | 0.533 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.734 |
LogD(Computed by ADMETlab 2.0) | 1.824 |
logP(Computed by ADMETlab 2.0) | 1.36 |
TPSA(Computed by SwissADME) | 113.29 Ų |
Hbond Acceptor(Computed by SwissADME) | 7 |
Hbond Donor(Computed by SwissADME) | 3 |
Rotatable Bonds(Computed by SwissADME) | 8 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.96 cm/s |
Lipinski(Computed by SwissADME) | Yes, 0 violation |
Ghose(Computed by SwissADME) | Yes |
Veber(Computed by SwissADME) | Yes |
Egan(Computed by SwissADME) | Yes |
Muegge(Computed by SwissADME) | Yes |
Bioavailability Score(Computed by SwissADME) | 0.55 |